V Thibault

Summary

Country: France

Publications

  1. pmc A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
    Carole Fournier
    Laboratoire de Virologie, Centre Hospitalo Universitaire, Amiens, France
    Virol J 4:35. 2007
  2. pmc Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus
    V Thibault
    Laboratoire de Virologie, Service d Hepato gastro enterologie, Service des Maladies Infectieuses, Groupe Hospitalier Pitie Salpetriere, 75013 Paris, France
    J Clin Microbiol 37:3013-6. 1999
  3. ncbi request reprint Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy
    Y Benhamou
    Service d Hepato Gastroenterologie, Service de Pharmacie, Service de Virologie, Service de Maladies Infectieuses, Groupe Hospitalier Pitie Salpetriere, Paris, France
    Hepatology 34:283-7. 2001
  4. ncbi request reprint Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study
    Y Benhamou
    Service d Hepato Gastroenterologie, Groupe Hospitalier Pitie Salpetriere, Paris, France
    Lancet 358:718-23. 2001
  5. pmc Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24
    David Saadoun
    Department of Internal Medicine, Service de Medecine Interne, AP HP, Groupe Hospitalier Pitie Salpetriere, Paris, France
    Ann Rheum Dis 73:831-7. 2014
  6. doi request reprint [Development and validation of a specific method for relative HBV-genotype G (G-HBV) quantification in the context of co-infection with other genotypes]
    N Desire
    ER 1, Universite Pierre et Marie Curie, 105, Boulevard de l Hopital, 75013 Paris, France
    Pathol Biol (Paris) 59:e13-9. 2011
  7. ncbi request reprint A prospective assessment of an 'a la carte' regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers
    C d'Arondel
    Service d Hepato Gastroenterologie, Groupe Hospitalier Pitie Salpetriere, Universite Paris VI, Paris, France
    J Viral Hepat 13:182-9. 2006
  8. pmc Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection
    V Avettand-Fenoel
    Virology Department, Groupe Hospitalier Pitie Salpetriere, Paris, France
    J Clin Microbiol 44:2250-3. 2006
  9. ncbi request reprint [Early detection of hepatitis C virus infection using a new combined antigen-antibody detection assay: potential use in HIV co-infected individuals]
    A Schnuriger
    Service de Virologie, Groupe Hospitalier Pitie Salpetriere, 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Pathol Biol (Paris) 54:578-86. 2006
  10. ncbi request reprint Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections
    T Andrieu
    Laboratoire de Virologie, CERVI, UPRES EA 2387, Groupe Hospitalier Pitie Salpetriere, 75651 Paris Cedex 13, France
    J Clin Virol 27:59-68. 2003

Collaborators

Detail Information

Publications23

  1. pmc A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
    Carole Fournier
    Laboratoire de Virologie, Centre Hospitalo Universitaire, Amiens, France
    Virol J 4:35. 2007
    ..Based on the recent development of a HCV cell culture system using the genotype 2 JFH-1-strain, we developed a focus reduction assay for HCV-neutralizing antibodies...
  2. pmc Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus
    V Thibault
    Laboratoire de Virologie, Service d Hepato gastro enterologie, Service des Maladies Infectieuses, Groupe Hospitalier Pitie Salpetriere, 75013 Paris, France
    J Clin Microbiol 37:3013-6. 1999
    ..This study demonstrates the emergence of particular genetic profiles in HBV-HIV-coinfected patients experiencing a loss of control of HBV infection despite high doses of lamivudine...
  3. ncbi request reprint Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy
    Y Benhamou
    Service d Hepato Gastroenterologie, Service de Pharmacie, Service de Virologie, Service de Maladies Infectieuses, Groupe Hospitalier Pitie Salpetriere, Paris, France
    Hepatology 34:283-7. 2001
    ....
  4. ncbi request reprint Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study
    Y Benhamou
    Service d Hepato Gastroenterologie, Groupe Hospitalier Pitie Salpetriere, Paris, France
    Lancet 358:718-23. 2001
    ..We assessed the safety and efficacy of a once daily dose of adefovir dipivoxil in an open-label trial for the treatment of lamivudine-resistant HBV infection in HIV-1-infected patients...
  5. pmc Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24
    David Saadoun
    Department of Internal Medicine, Service de Medecine Interne, AP HP, Groupe Hospitalier Pitie Salpetriere, Paris, France
    Ann Rheum Dis 73:831-7. 2014
    ..About 30-40% of patients are non-responders or relapsers to such combination...
  6. doi request reprint [Development and validation of a specific method for relative HBV-genotype G (G-HBV) quantification in the context of co-infection with other genotypes]
    N Desire
    ER 1, Universite Pierre et Marie Curie, 105, Boulevard de l Hopital, 75013 Paris, France
    Pathol Biol (Paris) 59:e13-9. 2011
    ..A detection and quantification method specific of genotype G hepatitis B virus (G-HBV) was developed and used to study the epidemiology and evolution of G-HBV co-infection during antiviral therapy...
  7. ncbi request reprint A prospective assessment of an 'a la carte' regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers
    C d'Arondel
    Service d Hepato Gastroenterologie, Groupe Hospitalier Pitie Salpetriere, Universite Paris VI, Paris, France
    J Viral Hepat 13:182-9. 2006
    ..It achieves a 73% SVR and a significant decrease in fibrosis and activity as estimated by biochemical markers...
  8. pmc Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection
    V Avettand-Fenoel
    Virology Department, Groupe Hospitalier Pitie Salpetriere, Paris, France
    J Clin Microbiol 44:2250-3. 2006
    ....
  9. ncbi request reprint [Early detection of hepatitis C virus infection using a new combined antigen-antibody detection assay: potential use in HIV co-infected individuals]
    A Schnuriger
    Service de Virologie, Groupe Hospitalier Pitie Salpetriere, 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Pathol Biol (Paris) 54:578-86. 2006
    ..The aim of this study was to determine the clinical benefit of a new combined antigen-antibody immunoenzymatic assay (Monolisa HCV Ag-Ab Ultra, Biorad) in the setting of acute HCV infection in HIV infected patients...
  10. ncbi request reprint Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections
    T Andrieu
    Laboratoire de Virologie, CERVI, UPRES EA 2387, Groupe Hospitalier Pitie Salpetriere, 75651 Paris Cedex 13, France
    J Clin Virol 27:59-68. 2003
    ..Dipeptidyl peptidase IV is a transmembrane enzyme widely expressed in many cell types, but also present as a soluble form in biological fluids. Its abnormal activity is sometimes associated with liver disease related pathologies...
  11. doi request reprint [Management of the risk of hepatitis B virus reactivation in patients receiving immunosuppressive and immunomodulatory agents in internal medicine: data from the REACTI-B survey and proposal for a management algorithm]
    B Terrier
    Service de Medecine Interne, Groupe Hospitalier Pitie Salpetriere, Paris, France
    Rev Med Interne 33:4-12. 2012
    ....
  12. ncbi request reprint Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study
    C Payan
    Laboratoire de Virologie, CHU Angers, France
    J Viral Hepat 12:405-13. 2005
    ..The modification of the HCV genotype pattern in France in the next 10 years may require new therapeutic strategies, and further survey studies...
  13. ncbi request reprint The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C
    R P Myers
    Department of Hepatology and Gastroenterology, Groupe Hospitalier Pitie Salpetriere, Paris, France
    J Viral Hepat 10:103-10. 2003
    ..36; 95% confidence interval, 0.45 to 4.06; P = 0.58). In conclusion, previous HBV infection does not affect liver histology or the response to IFN-based therapy in patients with chronic hepatitis C...
  14. ncbi request reprint Acute hepatitis C in HIV-infected men who have sex with men
    J Ghosn
    Departement des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    HIV Med 5:303-6. 2004
    ....
  15. ncbi request reprint Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma
    P Cacoub
    Service de Medecine Interne, CHU Pitie Salpetriere, Paris, France
    Clin Microbiol Infect 9:39-44. 2003
    ....
  16. ncbi request reprint Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C
    R Morra
    UMR CNRS 8149, Pharmacy Faculty, Paris 5 University, Paris, and Biopredictive, Paris, France
    Aliment Pharmacol Ther 26:847-58. 2007
    ..FibroTest has been validated for the diagnosis of liver fibrosis in patients with chronic hepatitis C...
  17. ncbi request reprint Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia
    P Cacoub
    Department of Internal Medicine, , Paris, France
    Arthritis Rheum 44:2118-24. 2001
    ..In contrast, HLA-DR7 appears to protect against the production of type II MC. These results suggest that the host's immune response genes may play a role in the pathogenesis of HCV-associated MC...
  18. pmc Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals
    A Schnuriger
    Department of Virology, hôpital La Pitié Salpêtrière, 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    J Clin Microbiol 44:1561-3. 2006
    ..Reduction of the long period of HCV seronegativity should improve the diagnosis of hepatitis C infection, especially in high-risk populations...
  19. ncbi request reprint Renal microaneurysms in three cases of hepatitis C virus-related vasculitis
    N Costedoat-Chalumeau
    Rheumatology (Oxford) 41:708-10. 2002
  20. pmc Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome
    D Sene
    Department of Internal Medicine, hôpital La Pitié Salpêtrière, 83 Boulevard de l hopital, 75651 Paris Cedex 13, France
    Ann Rheum Dis 65:394-7. 2006
    ..To investigate the diagnostic reliability of anti-CCP antibodies (anti-CCP Ab) in distinguishing hepatitis C virus (HCV) associated rheumatological manifestations and Sjögren's syndrome from rheumatoid arthritis...
  21. ncbi request reprint [Peripheral neuropathy and hepatitis C virus infection: more than cryoglobulinemia]
    O Lidove
    , , 40, rue Worth, 92151 Suresnes, France
    Rev Med Interne 22:939-47. 2001
    ..Low doses of interferon alpha may worsen peripheral neuropathy in patients with mixed cryoglobulinemia, as suggested in our later observations...
  22. ncbi request reprint [Nosocomial risk factors of hepatitis C infection. A multicenter study in a hospital-based population]
    S Maugat
    Centre de Coordination de la Lutte contre l Infection Nosocomiale pour l inter région Nord, Paris, Institut Biomedical des Cordeliers, 15 21, rue de l Ecole de Medecine, 75006 Paris
    Rev Epidemiol Sante Publique 51:301-8. 2003
    ..The aim of the study was to assess the prevalence and to identify risk factors for hepatitis C virus (HCV) infection in hospitalized patients frequently exposed to invasive procedures...
  23. ncbi request reprint Genetic heterogeneity of the hypervariable region I of Hepatitis C virus and lymphoproliferative disorders
    A Rigolet
    Virology Laboratory, Hopital Pitie Salpetriere, 75651 Paris, France
    Leukemia 19:1070-6. 2005
    ..Contrary to recent findings, our analysis based on multiple clones per patient analysis did not reveal any particular motif associated with BCLD...